USD 7.46
(-0.8%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 668.6 Million USD | 4.85% |
2022 | 637.7 Million USD | -2.04% |
2021 | 651 Million USD | -3.37% |
2020 | 673.7 Million USD | 15.96% |
2019 | 581 Million USD | 5.81% |
2018 | 549.1 Million USD | -15.51% |
2017 | 649.9 Million USD | 654.82% |
2016 | 86.1 Million USD | -2.16% |
2015 | 88 Million USD | 19.24% |
2014 | 73.8 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 661.5 Million USD | 0.33% |
2024 Q3 | 657.4 Million USD | -0.62% |
2024 Q1 | 659.3 Million USD | -1.39% |
2023 Q1 | 655.9 Million USD | 2.85% |
2023 Q4 | 668.6 Million USD | 0.27% |
2023 FY | 668.6 Million USD | 4.85% |
2023 Q3 | 666.8 Million USD | 1.35% |
2023 Q2 | 657.9 Million USD | 0.3% |
2022 Q3 | 635.3 Million USD | 1.13% |
2022 Q4 | 637.7 Million USD | 0.38% |
2022 Q1 | 632.9 Million USD | -2.78% |
2022 Q2 | 628.2 Million USD | -0.74% |
2022 FY | 637.7 Million USD | -2.04% |
2021 Q3 | 676.2 Million USD | 1.88% |
2021 FY | 651 Million USD | -3.37% |
2021 Q4 | 651 Million USD | -3.73% |
2021 Q1 | 672.7 Million USD | -0.15% |
2021 Q2 | 663.7 Million USD | -1.34% |
2020 FY | 673.7 Million USD | 15.96% |
2020 Q3 | 640.6 Million USD | 3.79% |
2020 Q4 | 673.7 Million USD | 5.17% |
2020 Q1 | 606.5 Million USD | 4.39% |
2020 Q2 | 617.2 Million USD | 1.76% |
2019 Q4 | 581 Million USD | -2.37% |
2019 FY | 581 Million USD | 5.81% |
2019 Q2 | 519.6 Million USD | -7.35% |
2019 Q3 | 595.1 Million USD | 14.53% |
2019 Q1 | 560.8 Million USD | 2.13% |
2018 Q2 | 561.6 Million USD | -8.12% |
2018 FY | 549.1 Million USD | -15.51% |
2018 Q4 | 549.1 Million USD | 1.24% |
2018 Q3 | 542.4 Million USD | -3.42% |
2018 Q1 | 611.2 Million USD | -5.95% |
2017 Q3 | 681.7 Million USD | 101.09% |
2017 FY | 649.9 Million USD | 654.82% |
2017 Q1 | 81.1 Million USD | -5.81% |
2017 Q2 | 339 Million USD | 318.0% |
2017 Q4 | 649.9 Million USD | -4.66% |
2016 Q3 | 82.5 Million USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2016 Q4 | 86.1 Million USD | 4.36% |
2016 FY | 86.1 Million USD | -2.16% |
2015 Q4 | 88 Million USD | 0.0% |
2015 FY | 88 Million USD | 19.24% |
2014 FY | 73.8 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Envoy Medical, Inc. | 9.4 Million USD | -7011.253% |
OrthoPediatrics Corp. | 72.56 Million USD | -821.432% |
Lucid Diagnostics Inc. | 29.58 Million USD | -2160.235% |
Nano-X Imaging Ltd. | 23.13 Million USD | -2790.118% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -157113.701% |
PAVmed Inc | 57.13 Million USD | -1070.17% |
Accelerate Diagnostics, Inc. | 51.25 Million USD | -1204.484% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | -2525.771% |
RxSight, Inc. | 22.18 Million USD | -2913.341% |
Sight Sciences, Inc. | 46.43 Million USD | -1339.831% |
SI-BONE, Inc. | 61.05 Million USD | -995.168% |
TELA Bio, Inc. | 59.16 Million USD | -1030.022% |
Treace Medical Concepts, Inc. | 113.96 Million USD | -486.651% |
Bioventus Inc. | 589.79 Million USD | -13.362% |
BrainsWay Ltd. | 15.31 Million USD | -4265.94% |
Vivos Therapeutics, Inc. | 10.31 Million USD | -6379.31% |
CVRx, Inc. | 39.28 Million USD | -1602.052% |
electroCore, Inc. | 8.94 Million USD | -7374.567% |
Helius Medical Technologies, Inc. | 5.34 Million USD | -12415.912% |
Inogen, Inc. | 121.38 Million USD | -450.823% |
IceCure Medical Ltd | 4.24 Million USD | -15642.877% |
Spectral AI, Inc. | 12.4 Million USD | -5291.501% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | -20912.319% |
MaxCyte, Inc. | 36.1 Million USD | -1751.719% |
Acutus Medical, Inc. | 54.83 Million USD | -1119.205% |
PetVivo Holdings, Inc. | 2.42 Million USD | -27422.332% |
Talis Biomedical Corporation | 29.22 Million USD | -2187.846% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -36081.416% |
Orthofix Medical Inc. | 326.58 Million USD | -104.725% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | -5491.2% |
Cerus Corporation | 144.3 Million USD | -363.327% |
Venus Concept Inc. | 107.1 Million USD | -524.259% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | -1194.156% |
LivaNova PLC | 1.15 Billion USD | 41.959% |
908 Devices Inc. | 37.49 Million USD | -1683.409% |
Alphatec Holdings, Inc. | 703.48 Million USD | 4.959% |
Nemaura Medical Inc. | 26.37 Million USD | -2434.743% |
NeuroPace, Inc. | 86.99 Million USD | -668.532% |
LENSAR, Inc. | 22.4 Million USD | -2883.623% |
Apyx Medical Corporation | 52.31 Million USD | -1177.954% |
Cutera, Inc. | 518.12 Million USD | -29.043% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | -2179.733% |
BioSig Technologies, Inc. | 4.68 Million USD | -14171.078% |
Anika Therapeutics, Inc. | 58.36 Million USD | -1045.51% |
ClearPoint Neuro, Inc. | 21.48 Million USD | -3011.504% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 69.527% |
Axonics, Inc. | 82.35 Million USD | -711.812% |
Outset Medical, Inc. | 190.91 Million USD | -250.208% |
IRIDEX Corporation | 24.91 Million USD | -2583.632% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | -439.346% |
IRadimed Corporation | 20.73 Million USD | -3124.354% |
Tivic Health Systems, Inc. | 1.67 Million USD | -39840.263% |
INVO Bioscience, Inc. | 19.99 Million USD | -3243.842% |
Telesis Bio, Inc. | 40.87 Million USD | -1535.799% |
Viemed Healthcare, Inc. | 40.79 Million USD | -1539.118% |
Quipt Home Medical Corp. | 136.29 Million USD | -390.561% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -18617.805% |
Pulmonx Corporation | 60.63 Million USD | -1002.645% |
Dynatronics Corporation | 11.78 Million USD | -5575.666% |
Modular Medical, Inc. | 2.27 Million USD | -29327.817% |
ReShape Lifesciences Inc. | 4.06 Million USD | -16351.772% |
Semler Scientific, Inc. | 6.27 Million USD | -10563.477% |
InMode Ltd. | 75.91 Million USD | -780.733% |
Bruker Corporation | 2.83 Billion USD | 76.43% |
Cytosorbents Corporation | 29.98 Million USD | -2129.747% |
DexCom, Inc. | 4.19 Billion USD | 84.065% |
Align Technology, Inc. | 2.45 Billion USD | 72.748% |
Viveve Medical, Inc. | 10.84 Million USD | -6063.916% |
ZimVie Inc. | 795.85 Million USD | 15.989% |
Movano Inc. | 5.97 Million USD | -11095.579% |
Cytek Biosciences, Inc. | 104.6 Million USD | -539.166% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -157113.701% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -5491.2% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | -4.628% |
Profound Medical Corp. | 12.66 Million USD | -5178.756% |
Insulet Corporation | 1.85 Billion USD | 63.967% |
enVVeno Medical Corporation | 2.43 Million USD | -27357.906% |
Surmodics, Inc. | 65.82 Million USD | -915.754% |
iCAD, Inc. | 8 Million USD | -8256.456% |
Nuwellis, Inc. | 6.78 Million USD | -9761.357% |
Biotricity, Inc. | 35.91 Million USD | -1761.387% |
iRhythm Technologies, Inc. | 223.04 Million USD | -199.757% |
Aethlon Medical, Inc. | 2.47 Million USD | -26863.483% |
InspireMD, Inc. | 8.14 Million USD | -8111.743% |
PAVmed Inc. | 57.13 Million USD | -1070.17% |
BIOLASE, Inc. | 35.34 Million USD | -1791.479% |
Beyond Air, Inc. | 29.77 Million USD | -2145.508% |
FONAR Corporation | 57.45 Million USD | -1063.641% |
AxoGen, Inc. | 101.16 Million USD | -560.92% |
Vivani Medical, Inc. | 25.03 Million USD | -2570.554% |
Tactile Systems Technology, Inc. | 87.79 Million USD | -661.538% |
Inari Medical, Inc. | 209.32 Million USD | -219.408% |
UFP Technologies, Inc. | 118.04 Million USD | -466.394% |
QT Imaging Holdings, Inc. | 12.69 Million USD | -5168.51% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -30488.175% |
Tenon Medical, Inc. | 5.56 Million USD | -11910.059% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -37482.912% |
Co-Diagnostics, Inc. | 17.63 Million USD | -3691.514% |
AdaptHealth Corp. | 3.15 Billion USD | 78.796% |
Sintx Technologies, Inc. | 6.59 Million USD | -10041.059% |
NanoVibronix, Inc. | 2.68 Million USD | -24792.033% |
Quanterix Corporation | 78.08 Million USD | -756.257% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -18617.805% |
Sensus Healthcare, Inc. | 4.88 Million USD | -13586.796% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 36.001% |
TransMedics Group, Inc. | 568.84 Million USD | -17.536% |
ReWalk Robotics Ltd. | 16.68 Million USD | -3907.913% |
NeuroMetrix, Inc. | 1.33 Million USD | -50052.874% |
Hyperfine, Inc. | 9.8 Million USD | -6722.449% |
Establishment Labs Holdings Inc. | 250.24 Million USD | -167.177% |
Biomerica, Inc. | 2.66 Million USD | -25007.022% |
Bone Biologics Corporation | 831.4 Thousand USD | -80318.378% |
AVITA Medical, Inc. | 19.86 Million USD | -3265.65% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -33775.754% |
Silk Road Medical, Inc | 114.15 Million USD | -485.679% |